The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis

Area of Science:

• Immunology
• Infectious Diseases
• Genetics

Background:

• Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is an intracellular sensor for bacterial muropeptides, including those from Mycobacterium tuberculosis (MTB).
• Experimental studies suggest NOD2 may hinder anti-mycobacterial mechanisms, potentially promoting MTB survival within macrophages.
• The role of NOD2 in tuberculosis pathogenesis requires further investigation.

Purpose of the Study:

• To investigate NOD2 transcriptional responses in pulmonary leukocytes and mononuclear cells from patients with pulmonary tuberculosis (PTB).
• To determine if NOD2 expression correlates with disease severity or treatment response in PTB.

Main Methods:

• Real-time PCR was used to analyze NOD2 mRNA expression in alveolar lavage cells from 15 PTB patients and controls.
• NOD2 expression was compared in peripheral leukocytes before and after anti-tuberculosis treatment in 10 patients.
• In vitro studies measured NOD2 mRNA levels in Mycobacterium tuberculosis-antigen stimulated mononuclear cells.

Main Results:

• No significant differences in NOD2 mRNA levels were found between PTB patients and controls.
• Some PTB patients exhibited elevated NOD2 expression, correlating with Toll-like Receptor 2 and 4 expression.
• NOD2 mRNA levels significantly increased in whole blood after anti-tuberculosis treatment completion.
• In vitro stimulation with mycobacterial antigens did not alter NOD2 expression in mononuclear cells.

Conclusions:

• Pulmonary tuberculosis is not characterized by specific NOD2 transcriptional responses.
• Elevated NOD2 expression in some severe PTB cases and post-treatment increases in peripheral leukocytes warrant further research.
• Future studies should focus on specific patient and control populations to elucidate NOD2's role in TB.